Literature DB >> 20049457

The fate of conference abstracts: systematic review and meta-analysis of surgical treatments for men with benign prostatic enlargement.

Susan Siu-Wan Wong1, Cynthia Fraser, Tania Lourenco, Daniel Barnett, Alison Avenell, Charis Glazener, Brian Cuthbertson, James N'Dow.   

Abstract

OBJECTIVE: From the literature search for a government-commissioned systematic review on surgical treatments for benign prostatic enlargement (BPE), we identified the relevant conference abstracts of randomised controlled trials (RCTs) which failed to reach full publication and their data were not utilised. We aimed to ascertain, first, the reasons of failure to reach full publication and second, to estimate the impact of including the abstracts' data.
DESIGN: A two-part study, consisting of a questionnaire survey and a sensitivity analysis of the above said review.
METHODS: An ad hoc questionnaire was sent to each author of the relevant abstracts, as to determine the reasons of failure to reach full publication. The data from the abstracts were then extracted and incorporated into sensitivity analysis of the review.
RESULTS: Forty-seven questionnaires were completed for 47 abstracts. Of these abstracts, 32 of them were claimed to have reached full publication. A number of reasons of failure to reach full publication were identified, for example: 'being written up' and 'lack of time'. Utilizable, relevant data were obtained from eight of the 47 abstracts, and put into sensitivity analysis. There were small changes in effect sizes and directions for three of 14 reviews' secondary outcomes.
CONCLUSION: Common reasons of failure to reach full publication were also identified in the context for the BPE review. Inclusion of abstract data did not affect primary outcome defined in the original review. Identification, summarisation of conference abstracts and other grey literature should form an essential exercise for any systematic review.

Entities:  

Mesh:

Year:  2010        PMID: 20049457     DOI: 10.1007/s00345-009-0500-3

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  18 in total

1.  Barriers to full-text publication following presentation of abstracts at annual orthopaedic meetings.

Authors:  Sheila Sprague; Mohit Bhandari; P J Devereaux; Marc F Swiontkowski; Paul Tornetta; Deborah J Cook; Douglas Dirschl; Emil H Schemitsch; Gordon H Guyatt
Journal:  J Bone Joint Surg Am       Date:  2003-01       Impact factor: 5.284

2.  Full publication of abstracts of randomised controlled trials published at International Continence Society meetings'.

Authors:  Peter Herbison
Journal:  Neurourol Urodyn       Date:  2004       Impact factor: 2.696

3.  The fate of abstracts submitted to a cancer meeting: factors which influence presentation and subsequent publication.

Authors:  C De Bellefeuille; C A Morrison; I F Tannock
Journal:  Ann Oncol       Date:  1992-03       Impact factor: 32.976

4.  From presentation to publication: the natural history of orthopaedic abstracts in the United Kingdom.

Authors:  E Guryel; A W Durrant; R Alakeson; D M Ricketts
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

5.  Factors associated with the full publication of studies presented in abstract form at the annual meeting of the American Urological Association.

Authors:  William A Smith; Quinton V Cancel; Timothy Y Tseng; Shahnaz Sultan; Johannes Vieweg; Philipp Dahm
Journal:  J Urol       Date:  2007-03       Impact factor: 7.450

Review 6.  Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies.

Authors:  Y Dundar; S Dodd; R Dickson; T Walley; A Haycox; P R Williamson
Journal:  Health Technol Assess       Date:  2006-02       Impact factor: 4.014

7.  Publication bias and clinical trials.

Authors:  K Dickersin; S Chan; T C Chalmers; H S Sacks; H Smith
Journal:  Control Clin Trials       Date:  1987-12

8.  Full publication of results initially presented in abstracts. A meta-analysis.

Authors:  R W Scherer; K Dickersin; P Langenberg
Journal:  JAMA       Date:  1994-07-13       Impact factor: 56.272

Review 9.  Grey literature in meta-analyses of randomized trials of health care interventions.

Authors:  S Hopewell; S McDonald; M Clarke; M Egger
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

Review 10.  Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials.

Authors:  Tania Lourenco; Robert Pickard; Luke Vale; Adrian Grant; Cynthia Fraser; Graeme MacLennan; James N'Dow
Journal:  BMJ       Date:  2008-10-09
View more
  5 in total

Review 1.  Authors report lack of time as main reason for unpublished research presented at biomedical conferences: a systematic review.

Authors:  Roberta W Scherer; Cesar Ugarte-Gil; Christine Schmucker; Joerg J Meerpohl
Journal:  J Clin Epidemiol       Date:  2015-02-13       Impact factor: 6.437

2.  Outcomes of Retzius-sparing versus conventional robot-assisted radical prostatectomy: A KSER update series systematic review and meta-analysis.

Authors:  Doo Yong Chung; Hae Do Jung; Do Kyung Kim; Min Ho Lee; Sin Woo Lee; Sunghyun Paick; Joo Yong Lee; Seung Hyun Jeon
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

3.  Full publication of results initially presented in abstracts.

Authors:  Roberta W Scherer; Joerg J Meerpohl; Nadine Pfeifer; Christine Schmucker; Guido Schwarzer; Erik von Elm
Journal:  Cochrane Database Syst Rev       Date:  2018-11-20

Review 4.  Why are medical and health-related studies not being published? A systematic review of reasons given by investigators.

Authors:  Fujian Song; Yoon Loke; Lee Hooper
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

5.  ClinicalTrials.gov registration can supplement information in abstracts for systematic reviews: a comparison study.

Authors:  Roberta W Scherer; Lynn Huynh; Ann-Margret Ervin; Jakeisha Taylor; Kay Dickersin
Journal:  BMC Med Res Methodol       Date:  2013-06-18       Impact factor: 4.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.